Login / Register
CME Event Calendar
CME Online Activities
Other Activities
Peer-to-Peer Dialogue
CME Information
| Activity Title | Peer-to-Peer Dialogue #6 |
| Topic | Clinical perspectives on HIT diagnosis and management |
| Target Audience | Critical care nurses, emergency physicians, general surgeons, hematologists, hospitalists, and hospital administrators who manage heparin-induced thrombocytopenia |
| Accreditation Type | CME |
| Release Date | November 2009 |
| Expiration Date | November 30, 2010 |
| Estimated Time to Complete Activity | 10 minutes |
LEARNING OBJECTIVE
Upon completion of the activity, participants should be able to:
- Utilize practical tools for raising HIT awareness and improving its management in the hospital setting
FACULTY
Jerrold H. Levy, MD, FAHA
Professor and Deputy Chair for Research, Critical Care and Cardiothoracic Anesthesiology
Director, Cardiothoracic Anesthesiology
Emory University School of Medicine
Atlanta, Georgia
Lawrence Rice, MD
Professor of Medicine
Chief of Hematology
Cornell Weill Medical College-Houston
Clinical Service Chief of Hematology/Oncology
The Methodist Hospital
Houston, Texas
Kathleen Shaughnessy, MSN, CRNP, CCRN
Clinical Director, Cardiac Surgery
Porter Institute for Valvular Heart Disease
Abington Memorial Hospital
Abington, Pennsylvania
METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT
- There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives and CME information.
- Complete the CME activity
- Complete the CME evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
- Your CME certificate will be emailed to you within 4 weeks.
SPONSOR
This activity is sponsored by The France Foundation.
 |
TARGET AUDIENCE
Critical care nurses, emergency physicians, general surgeons, hematologists, hospitalists, and hospital administrators who manage heparin-induced thrombocytopenia.
STATEMENT OF NEED
This activity has been planned in accordance with the need to provide education surrounding the latest clinical information on identification and management of heparin-induced thrombocytopenia (HIT).
ACCREDITATION STATEMENT
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION
Physicians
The France Foundation designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
RESOLUTION OF CONFLICTS OF INTEREST
In accordance with the ACCME Standards for Commercial Support of CME, The France Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.
DISCLOSURE
It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff involved in the development of this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all conflicts of interest prior to the release of this activity.
Activity Staff Disclosures
The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.
Faculty Disclosures
The following faculty have indicated they have no relationships with industry to disclose relative to the content of this CME activity:
- Kathleen Shaughnessy, MSN, CRNP, CCRN
The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME activity:
- Jerrold Levy, MD, has received grants/research support from Lilly and Novo. He has served as a consultant for CSL Behring, Cubist, Medicines Company, Novo, and Schering-Plough.
- Lawrence Rice, MD, is currently participating in a multi-center study sponsored by Canyon Pharma. He has served as a consultant for Canyon Pharma and GlaxoSmithKline. He has received honoraria from Amgen, GlaxoSmithKline, and Novartis.
UNAPPROVED USE DISCLOSURE
The France Foundation requires CME faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by an educational grant from GlaxoSmithKline.
DISCLAIMER
The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and GlaxoSmithKline assume no liability for the information herein.
COPYRIGHT INFORMATION
Copyright © 2009 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:
- The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
- Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.
PRIVACY POLICY
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.
The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.
Additional information regarding The France Foundation's Privacy Policy can be viewed at http://www.francefoundation.com/privacy.
CONTACT INFORMATION
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.
Upon completion of this activity, please complete the CME Attestation.